 |
인쇄하기
취소
|
Daewha's Paclitaxel formula successfully completed clinical tests.
Daewha announced on Nov. 29 that the patent registration for the manufacturing process of a soluble and mucus absorbable formula of paclitaxel from its original insoluble substance had been completed.
The company said that the patent of this new DDS formula showed significant advantages in its long term stability and solubility applicable to the formulas compositing with paclitaxel, an anti-...
The company said that the patent of this new DDS formula showed significant advantages in its long term stability and solubility applicable to the formulas compositing with paclitaxel, an anti-...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.